Obesity-associated inflammation can impair insulin signaling through serine phosphorylation of insulin receptor substrate-1 (IRS-1) and inhibiting phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, resulting in impaired glucose uptake. Here, INS is linked to obesity disorder.